Xtant Medical Holdings (XTNT) Misses Q2 EPS by 5c

Xtant Medical Holdings (NYSE: XTNT) reported Q2 EPS of ($0.07), $0.05 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $23.03 million versus the consensus estimate of $24.48 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c